Iron Deficiency Anemia Therapy Market Size, Share, and Growth Forecast 2026 – 2033

The global iron deficiency anemia therapy market size is expected to be valued at US$ 5.2 billion in 2026 and projected to reach US$ 8.7 billion by 2033, growing at a CAGR of 7.6% between 2026 and 2033. Anemia is a physio-health condition driven by nutritional disorders, affecting nearly 30% of the global population, particularly women and children. The condition arises when hemoglobin levels fall due to inadequate iron intake, absorption issues, or chronic blood loss, leading to fatigue, weakness, and impaired immunity. High-risk groups include young children, adolescent girls, pregnant women, and postpartum mothers, making effective therapies critical for public health systems worldwide.